RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$6.38
−2.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.01x
- Price / sales
- 2.08x
- Price / cash flow
- -11.66x
Enterprise value
- Enterprise value
- $66.9M
- EV / sales
- 0.52x
- EV / EBITDA
- -1.55x
- EV / EBIT
- -1.21x
- Market cap
- $265.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026